KK
REGN icon

KLP Kapitalforvaltning’s Regeneron Pharmaceuticals REGN Stock Holding History

KLP Kapitalforvaltning’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$44.5M Buy
71,388
+13,080
+22% +$8.9M 0.14% 121
2026
Q1 		$45.1M Buy
58,308
+6,640
+13% +$5.08M 0.18% 105
2025
Q4 		$39.9M Buy
51,668
+80
+0.2% +$54.3K 0.15% 120
2025
Q3 		$29M Buy
51,588
+10,100
+24% +$5.71M 0.12% 167
2025
Q2 		$21.8M Sell
41,488
-7,200
-15% -$4.02M 0.09% 211
2025
Q1 		$30.9M Buy
48,688
+300
+0.6% +$206K 0.15% 131
2024
Q4 		$34.5M Buy
+48,388
New +$40.6M 0.16% 116

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

KLP Kapitalforvaltning's REGN Position: Q2 2026 in Review

KLP Kapitalforvaltning increased its Regeneron Pharmaceuticals (REGN) stake by 22% in Q2 2026, buying an estimated $8.9M and bringing the position to 71,388 shares worth $44.5M. The position accounts for 0.14% of the portfolio, ranked #121.

KLP Kapitalforvaltning first reported a position in REGN in Q4 2024 and has held it in 7 quarters since. The position peaked at $45.1M in Q1 2026. 1,332 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • KLP Kapitalforvaltning held 71,388 shares of Regeneron Pharmaceuticals worth $44.5M as of Q2 2026.
  • KLP Kapitalforvaltning bought 13,080 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $8.9M.
  • Regeneron Pharmaceuticals made up 0.14% of KLP Kapitalforvaltning's portfolio in Q2 2026, its #121 holding.
  • KLP Kapitalforvaltning first reported a position in Regeneron Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • KLP Kapitalforvaltning's Regeneron Pharmaceuticals position peaked at $45.1M in Q1 2026.
  • 1,332 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q2 2026, filed 12 Aug 2026.